Oryzon Genomics (STU:ORN) Price-to-Operating-Cash-Flow : (As of Jun. 10, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Oryzon Genomics Price-to-Operating-Cash-Flow?

As of today (2024-06-10), Oryzon Genomics's share price is €1.942. Oryzon Genomics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.00. Hence, Oryzon Genomics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Oryzon Genomics's Price-to-Operating-Cash-Flow or its related term are showing as below:

STU:ORN's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.02
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Oryzon Genomics's Cash Flow from Operations per share for the three months ended in Mar. 2024 was €0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 52.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 15.50% per year.

During the past 10 years, Oryzon Genomics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 52.30% per year. The lowest was -59.50% per year. And the median was 21.20% per year.

Oryzon Genomics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Oryzon Genomics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oryzon Genomics Price-to-Operating-Cash-Flow Chart

Oryzon Genomics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Oryzon Genomics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Oryzon Genomics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Oryzon Genomics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oryzon Genomics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oryzon Genomics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Oryzon Genomics's Price-to-Operating-Cash-Flow falls into.

Oryzon Genomics Price-to-Operating-Cash-Flow Calculation

Oryzon Genomics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	1.942	/	0
	=

Oryzon Genomics's Share Price of today is €1.942.
Oryzon Genomics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Oryzon Genomics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Oryzon Genomics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Oryzon Genomics (STU:ORN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oryzon Genomics SA (STU:ORN) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

ORYZF:USA ORY:Spain

Address

Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940

Website

http://www.oryzon.com

Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.